EU Expected to Clear Kimberly-Clark's $40B Kenvue Deal in Phase 1
KMB is trading near its 52-week low of $92.42 (6.1% above the low) on light trading volume (0.1× avg).
Summary
The European Commission is expected to approve Kimberly-Clark's $40 billion acquisition of Kenvue in its phase 1 review, with remedies, according to a Capitol Forum report cited by traders. The main overlap is in feminine care products, and the EC is set to formally inform the company of its concerns this week, with a state-of-play meeting also expected. This follows Australia's conditional clearance earlier this month, which required divesting Kenvue's Carefree and Stayfree brands in that market. A phase 1 approval would remove a major regulatory hurdle and likely accelerate deal completion, though the specific remedies required by the EU remain to be seen. The Sept. 29 deadline for the EC's decision is the next key date.
At the time of this announcement, KMB was trading at $98.06 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $32.6B. The 52-week trading range was $92.42 to $127.78. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.